<table><tr><th>To: </th><th></th><th>Jeffrey Epsteinfleevacationepgmail.comi</th></tr><tr><td>Cc:</td><td>Woodson Merrell</td><td></td></tr><tr><td>From:</td><td>woodson merrell</td><td></td></tr><tr><td>Sent:</td><td>Wed 11/24/2010 12:50:03 AM</td><td></td></tr><tr><td>Subject:</td><td>bacteriophage information</td><td></td></tr></table>

Jeffrey,

This should qualify as cutting edge research science with tremendous clinical applications, especially for treatment of drug-resistant infections (? and investment potential).

Best,

Woody

http://en.wikipedia.org/wiki/Bacteriophage

good description of bacteriophages: history, science, and applications

http://www.phageinternational.com/about.htm

website of the research company Phage International (assoc with Georgia, Russia lab): (my cousin Wm Jouris is an advisor in this one)

http://www.phageinternational.com/ptc.htm

about Phage International's collaboration with the clinical center in Georgia currently treating chronic resistant bacterial infections with phages

http://www.biochimpharm.ge/content.php?id=15

the main Georgian company doing the research and treatment

http://www.phage.com/home1.html

website of US research company Omnilytics (some USDA approved salmonella treatment for cattle)